Clinical Trial Update: Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)

View source ↗

Summary

This is a completed Special Drug Use Investigation of fondaparinux (ARIXTRA) under a regulatory program for cardiovascular disease use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cardiovascular Disease | Status: COMPLETED